Aldara for Basal cell carcinoma treatment

We have 108 consumer reports for treatment of Basal cell carcinoma with Aldara. Basal cell carcinoma used in 6% of cases.

Patients statistics on Basal cell carcinoma for Aldara


Average weight in Lbs

Average height in Ft
5′ 6″
5′ 11″

Average age

Aldara Circle Diagram 6 consumers of 108 reported about Basal cell carcinoma

  1. Emma G. Macdonald says:
    2.5 rating

    Aldara for Basal cell carcinoma

    Constant nausea throughout the entire application period; Circulatory disorders; severe back pain during the first 14 days.

    Side effects: Nausea; Back pain
  2. Richard E. Frye says:
    1.5 rating

    Aldara for Basal cell carcinoma

    Fatigue. Strong wheals on the upper body at the back and in front after the 4th day of intake. Itching. Defacement by inflammatory spots. Visit to the doctor: drug discontinued. Impact assessment corresponds to the condition of the inflammatory spots.

    Side effects: Skin lesions; Fatigue; Itching
  3. Douglas H. Horn says:
    3.5 rating

    Aldara for Basal cell carcinoma

    Complete removal of the basaliomas Adverse effects no disadvantage: The affected cells form oozing or crusty spots, which disappear again after the drug has been discontinued without scarring.

    Side effects: No side effects